Researcher Next
Create account
← Back to directory

Federico Cappuzzo

Researcher Next ID · RN-005525

Researcher · Medicine

Cancer Institute (WIA)

Chennai, India

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
825
Citation count
49,798
H-index
89
i10-index
275

Research interests

Medicine
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Lung Cancer Research Studies
Colorectal Cancer Treatments and Studies
Lung Cancer Diagnosis and Treatment

Publications

  • Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

    The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30167-6

  • Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

    New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716948

  • First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer

    New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1408440

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70130-3

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Science · 2007 · https://doi.org/10.1126/science.1141478

Current projects

    No projects listed.